๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea ยท Delayed Price ยท Currency is KRW
2,290.00
-60.00 (-2.55%)
Nov 18, 2026, 3:30 PM KST

HLB Life Science Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
55,98845,75232,77197,99099,59153,494
Revenue Growth
24.82%39.61%-66.56%-1.61%86.17%-41.73%
Gross Profit
-5,760-721.6-3,634-925.04-3,222-5,661
Operating Income
-25,340-21,035-19,984-25,493-19,950-18,329
Net Income
-22,846-99,7946,138-5,983-54,277-49,152
Earnings Per Share
-187.66-819.3754.46-59.00-537.56-494.76
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other
8,8946,1025,8604,9925,1674,545
Medicare Division
39,16935,12728,01730,18735,785-
Bio Development
356.94358.95788.51425.99312.9812.68
Construction and Engineering
7,1215,3461,0071,3625,88611,575
Internal Sales
--1,182-2,902-2,393-1,618-372.94
Total
54,35845,75232,77197,99099,59153,494

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
16,07413,87879,56678,860131,989139,961
Total Debt
141,879160,357123,783166,578147,4734,621
Net Cash (Debt)
-125,804-146,479-44,217-87,718-15,484135,340
Net Cash Growth
------7.71%
Net Cash Per Share
-1031.73-1202.24-392.35-861.84-153.361362.33

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25,763-22,933-32,005-10,016-29,744-14,084
Capital Expenditures
-11,422-25,582-27,296-20,618-10,676-2,421
Free Cash Flow
-37,185-48,515-59,301-30,634-40,420-16,505
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-10.29%-1.58%-11.09%-0.94%-3.23%-10.58%
Operating Margin
-45.26%-45.98%-60.98%-26.02%-20.03%-34.26%
Pretax Margin
-84.49%-219.81%11.14%-6.64%-61.09%-100.24%
Profit Margin
-40.80%-218.12%18.73%-6.11%-54.50%-91.88%
FCF Margin
-66.42%-106.04%-180.96%-31.26%-40.59%-30.85%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--198.66---
PS Ratio
4.9810.3237.2111.9010.8222.23